Prosecution Insights
Last updated: August 17, 2026

Examiner: SIMMONS, CHRIS E

Tech Center 1600 • Art Units: 1612 1622 1629

This examiner grants 34% of resolved cases

Performance Statistics

34.5%
Allow Rate
-25.5% vs TC avg
721
Total Applications
+19.3%
Interview Lift
1510
Avg Prosecution Days
Based on 676 resolved cases, 2023–2026

Rejection Statute Breakdown

1.4%
§101 Eligibility
11.9%
§102 Novelty
46.2%
§103 Obviousness
25.9%
§112 Clarity

Currently Pending Office Actions

App #TitleStatusAssignee
19446148 METHODS AND COMPOSITIONS FOR TREATING GLUCOCORTICOID EXCESS Final Rejection Sparrow Pharmaceuticals, Inc.
17728246 WHOLE MOUTH MALADOR CONTROL BY A COMBINATION OF ANTIBACTERIAL AND DEODORIZING AGENTS Final Rejection The Procter & Gamble Company
17899272 METHODS AND MATERIALS FOR ASSESSING AND TREATING ARTHRITIS Non-Final OA Mayo Foundation for Medical Education and Research
17437643 COMPOSITIONS, METHODS FOR REGULATING UTERINE, PLACENTAL GROWTH Non-Final OA The Regents of the University of California
17387129 INHIBITION OF MAMMALIAN TARGET OF RAPAMYCIN Final Rejection Southwest Research Institute

Facing This Examiner?

IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.

Build Your Strategy

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month